Relmada Therapeutics (RLMD) Price to Book (2014 - 2026)
Relmada Therapeutics' Price to Book came in at 3.57 for Q2 2026, up 186.2% from 1.25 a year earlier and up 29.7% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Price to Book (2014 - 2026) Analysis & Trends
For FY2025, Relmada Therapeutics' Price to Book was 2.20, up 399.0% from FY2024.
- Going back by year, Price to Book was 0.44 in FY2024 (-69.7%), 1.46 in FY2023 (+95.2%), 0.75 in FY2022 (-60.6%) and 1.90 in FY2021 (-61.7%).
- The five-year range for quarterly Price to Book is 0.40 (Q1 2025) to 7.05 (Q3 2025).
- Year-over-year, Price to Book has increased for four consecutive quarters, with growth averaging 172.9% over the last eight quarters.
- The fastest year-over-year change in Price to Book over five years came in Q1 2026 (growth of 590.0%), and the weakest in Q3 2023 (a decline of 85.9%).
- Business Quant data shows RLMD's Price to Book at 2.76 (Q1 2026), 2.20 (Q4 2025) and 7.05 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.57 |
| Mar 31, 2026 | 2.76 |
| Dec 31, 2025 | 2.20 |
| Sep 30, 2025 | 7.05 |
| Jun 30, 2025 | 1.25 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 2.05 |
| Jun 30, 2024 | 1.47 |
| Mar 31, 2024 | 1.95 |
| Dec 31, 2023 | 1.46 |
| Sep 30, 2023 | 0.90 |
| Jun 30, 2023 | 0.67 |
| Mar 31, 2023 | 0.54 |
| Dec 31, 2022 | 0.75 |
| Sep 30, 2022 | 6.37 |
| Jun 30, 2022 | 2.90 |
| Mar 31, 2022 | 2.25 |
| Dec 31, 2021 | 1.90 |
| Sep 30, 2021 | 6.31 |
API Access
Relmada Therapeutics Price to Book API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-book&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-book", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-book&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();